期刊
MAGNETIC RESONANCE IN MEDICINE
卷 77, 期 5, 页码 1853-1865出版社
WILEY
DOI: 10.1002/mrm.26264
关键词
MTR; CEST; APT; NOE; brain tumor
资金
- National Institutes of Health [R01EB009731, R01CA166171, R01NS083435, R21EB015555, P41EB015909]
- National Natural Science Foundation of China [8136112 0392]
PurposeTo evaluate the reliability of four CEST imaging metrics for brain tumors, at varied saturation power levels and magnetic field strengths (3-9.4 Tesla (T)). MethodsA five-pool proton exchange model (free water, semisolid, amide, amine, and NOE-related protons) was used for the simulations. For the in vivo study, eight glioma-bearing rats were scanned at 4.7T. The CEST ratio (CESTR), CESTR normalized with the reference value (CESTRnr), inverse Z-spectrum-based (MTRRex), and apparent exchange-related relaxation (AREX) were compared. ResultsThe simulated CEST signal intensities using MTRRex and AREX were substantially increased at relatively high radiofrequency (RF) saturation powers at 3T and 4.7T, whereas CESTR and CESTRnr metrics remained relatively stable. There were tremendously high MTRRex and AREX signals around the water frequency at all field strengths because of the small denominators. In the rat tumor study at 4.7T, both CESTR and CESTRnr showed clear contrasts in the tumor with respect to the normal tissue across all saturation power levels (0.5-3T), whereas the AREX showed negligible to negative insignificant contrasts. ConclusionsCEST metrics must be carefully selected based on the different experimental settings. CESTR and CESTRnr are more reliable at 3T (a clinical field strength) and 4.7T. Magn Reson Med 77:1853-1865, 2017. (c) 2016 International Society for Magnetic Resonance in Medicine
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据